For the “Advances in Laboratory Technology” session, the BHS invited two excellent scientists to discuss novel laboratory techniques that are ready – or almost ready – to enter routine haematological clinical practice. First, Dr. Peter J.M. Valk (Erasmus University Medical Center, Rotterdam, The Netherlands) talked about novel techniques for minimal residual disease (MRD) testing in haematological patients. Subsequently, Dr. Barbara Dewaele (University Hospital Leuven, Belgium) shared her experience on optical genome mapping in acute myeloid leukaemia and acute lymphoid leukaemia.
